Furthermore, high expression of HJURP is associated with poor prognosis in patients with colorectal and ovarian cancer and is an independent prognostic biomarker for those cancers (Li et al., 2018; Kang et al., 2020). Here, HJURP is linked to ovarian carcinoma.